New developments in the treatment of ADHD

J Clin Psychiatry. 2006 Jan;67(1):148-59. doi: 10.4088/jcp.v67n0121.

Authors

Joseph Biederman¹, Amy F T Arnsten, Stephen V Faraone, Alysa E Doyle, Thomas J Spencer, Timothy E Wilens, Margaret D Weiss, Steven A Safren, Larry Culpepper

Affiliation

¹ Dept. of Psychiatry, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA.

PMID: 16426101
DOI: 10.4088/jcp.v67n0121

No abstract available

Publication types

Congress
Research Support, Non-U.S. Gov't

MeSH terms

Antidepressive Agents, Tricyclic / therapeutic use
Atomoxetine Hydrochloride
Attention Deficit Disorder with Hyperactivity / drug therapy*
Attention Deficit Disorder with Hyperactivity / therapy*
Benzhydryl Compounds / therapeutic use
Bupropion / therapeutic use
Central Nervous System Stimulants / therapeutic use
Child
Clonidine / therapeutic use
Cognitive Behavioral Therapy / trends
Guanfacine / therapeutic use
Humans
Modafinil
Nicotinic Agonists / therapeutic use
Physician's Role
Primary Health Care
Propylamines / therapeutic use
Treatment Outcome

Substances

Antidepressive Agents, Tricyclic
Benzhydryl Compounds
Central Nervous System Stimulants
Nicotinic Agonists
Propylamines
Bupropion
Guanfacine
Atomoxetine Hydrochloride
Clonidine
Modafinil